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   We examine inhibition of tachyplesin I on DNA digestion with ten kinds of restriction enzymes. 
Tachyplesin I suppresses DNA cutting by these restriction enzymes regardless of sequence preference of 
the endonucleases. Competition of tachyplesin I with DNA binding of transcription factor Spl to GC box 
DNA is also investigated by using of methylation protection analysis. Tachyplesin I evidently inhibits the 
formation of Spl-DNA complex. The results suggest considerably low sequence-specific DNA-binding of 
tachyplesin I. 
KEY WORDS: Tachyplesin I / Peptide-DNA interaction / DNA binding protein / Restriction 
            endonuclease / Competition assay 
                                      Introduction
   Tachyplesin I is a small cationic peptide consisting of a rigid antiparallel /3-sheet (Figure 
1) . The peptide exhibits strong antimicrobial activity and has broad-spectrum against Gram-
positive, -negative bacteria, and fungi [1,2] . Cytotoxicity against mammalian cells and in- 
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                       Figure 1. Chemical structure of tachyplesin I. 
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hibitory effects on the proliferation of human immunodeficiency virus  (HIV) are also reported 
[3] . Little is known about mechanism of the cytotoxicity of tachyplesin I against the various 
targets. Recently, we presented DNA binding property of tachyplesin I by using several foot-
printing techniques and suggested that DNA may be one of the biological targets of tachyple-
sin I [4] . 
   In this study, we have demonstrated that tachyplesin I inhibits various sequence-specific 
protein binding to DNA. We investigated blocking effect of tachyplesin I on DNA cleavage by 
various restriction endonucleases. Methylation protection analysis was also used to study 
competition of tachyplesin I with Spl zinc finger domain [5] for GC box sequence. Sequence-
specificity for DNA binding of tachyplesin I has been discussed from these experimental 
results. 
                              Materials and Methods 
   Materials. Synthetic tachyplesin I was offered by Prof. N. Fujii (Kyoto University) . 
The Spl fragment, Spl (167 *) was prepared and purified as described previously [5] . 
Sspl,EcoRI,BamHI,SmaI,and Sall were obtained from Takara Shuzo (Kyoto, Japan) . BanII 
was purchased from Toyobo (Japan) . EcoRV and RsaI were obtained from Nippon gene 
(Japan) . Fokl restriction endonuclease was a kind gift of Drs. M. Takanami and H. Sugisaki 
(Kyoto University) . All other chemicals used were of commercial reagent grade. 
   Restriction Endonuclease Inhibition Assay. Linearized plasmid DNA (0.4 p g) was 
preincubated with tachyplesin I at 37°C for 15 min in the respective incubation buffer (final 
volume, 20 p 1) for each restriction enzyme in the absence of dithiothreitol. The enzyme 
(SspI, EcoRI, EcoRV ,BamHI , Smal, Sail , or FokI) was added (10 units) to the sample and incu-
bated at 37°C for 60 min. The incubation with the restriction enzyme BanII (2 units) or Rsal 
(5 units) was carried out at 37°C for 120 min or 40 min, respectively. The sample was ex-
tracted with phenol/chloroform, and subsequent extraction was performed with chloroform. 
Then, DNA was recovered by ethanol precipitation. The electrophoresis was performed by 
using a 1 % agarose containing ethidium bromide (0.5 u g/ml) . 
   Methylation Protection Analysis. The reaction mixture (final volume, 20 p1) contained 
the 32P end-labeled DNA fragment (pBR322 BstNI-HaeIII (105 bp)) , souicated calf thymus 
DNA (0.4 jig) , and tachyplesin I in 20 mM Tris-HC1 (pH 7.5) . After preincubation at 20°C 
for 15 min, Spl (167*) (final 2.3 pM) was added to the sample solution, and the sample was 
incubated for 15 min. Methylation was initiated by addition of 5 % dimethyl sulfate (DMS) (2 
pl) and then the reaction mixture was incubated for 5 min. The reaction was terminated by 
addition of 5 p 1 of DMS stop solution (1.5 M acetate buffer (pH 7.0) , 1 M /9 -mer-
captoethanol, and 250 p g/ml yeast tRNA) , and 75 ul of cold ethanol. The DNA was reco-
vered by centrifugation at 15000 rpm for 10 min, and then the ethanol precipitation was car-
ried out again. After rinsing and drying, the sample was treated with 1 M piperidine at 90°C 
for 30 min. Electrophoresis was performed in a 10 % polyacrylamide / 7 M urea slab gel at 
2000 V for 3 hr. After electrophoresis, an autoradiogram was made by 32P end-labeled DNA 
in the gel. DNA sequencing was carried out by the Maxam-Gilbert method [6] . The radioac-
tivity of each sample subjected to electrophoresis was approximately 10000 cpm. 
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                             Results and Discussion
   We demonstrated DNA binding of tachyplesin I by using of several footprinting analysis 
[4] . In the previous  study, some obvious footprints were observed. However, preferential 
sequences for DNA binding of the peptide were not specialized. To clarify whether the pep-
tide has sequence-specific DNA binding or not, we examined DNA cleavage analysis with res-
triction endonuclease in the presence of tachyplesin I. Figures 2-4 show the effect of 
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• Figure 2. Effect of tachyplesin I on DeaI activity. PvuII-linearized pBR322 fragments were digested by 
     Deal in the presence and absence of tachyplesin I. The tachyplesin I concentrations in lanes 2-10 
     were 0, 0.5, 1, 2, 5, 10, 25, 50, and 100 fe g/ml, respectively. Lane 1 shows intact 
     PvuII-digested pBR322. 
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Figure 3. Effect of tachyplesin I on SmaI activity. Eco0109-linearized pUC19 fragments were digested by 
     SmaI in the presence and absence of tachyplesin I. The tachyplesin I concentrations in lanes 2-9 
     were 0, 0.5, 1, 2, 5, 10, 25, and 50,ag/ml, respectively. Lane 1 shows intact Eco0109-digested 
     pUC19. 
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tachyplesin I on restriction endonuclease activities. Inhibitory effect of the peptide on DNA 
digestion with  Dral which cleaves the DNA at 5'-TTTAAA-3' was apparently detected at 0.5 
a g/ml (0.22,aM) (Figure 2; lane 3) . Up to 10 ag/ml, tachyplesin I gradually inhibited DNA 
digestion by DraI depended upon the peptide-concentration (lanes 2-7) . Above 10 , ag/ml, the 
inhibition dramatically proceeded, and DNA cutting with DraI was completely suppressed at 
50 fig/m1 (lane 9) . Similar inhibitory effect of tachyplesin I against digestion with SmaI rec-
ognizing GC-rich sites, 5'-CCCGGG-3', was also observed (Figure 3) . In the case of SmaI, 
the inhibitory effect of tachyplesin I remarkably proceeded from the peptide concentration of 
25 pg/ml (lanes 8 and 9) . We also tested inhibition for digestion with nine kinds of restric-
tion enzymes; DraI,SspI,EcoRI,EcoRV,BamHI,BanII,Smal,Sall, and Fokl, by tachyplesin I at 
concentrations of 1, 10, 40, and 100 ug/ml. The results and the recognition sequences of 
these restriction enzymes studied are summarized in Table 1. Tachyplesin I evidently 
A 
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Figure 4. Effect of tachyplesin I on Rsal activity. (A) PvuII-linearized pBR322 fragments were digested 
     by Rsal in the presence and absence of tachyplesin I. The tachyplesin I concentrations in lanes 
     2-11 were 0, 0.2, 0.5, 1, 2, 5, 10, 20, 50, and 100 pg/ml, respectively. Lane 1 shows intact 
PvuII-digested pBR322. (B) pBR322 linearized with PvaII (position 2068) . The three cleavage sites 
     for RsaI are indicated by arrows. Two sites blocked by tachyplesin I are displayed by crosses su-
     perimposed on the arrows. 
( 248)
                         DNA Interaction with Tachyplesin I
Table 1. Protection of Recognition Sites of Various Restriction  Endonucleases by Tachyplesin I 
     After preincubation of linearized plasmid DNA (0.4 pg) with tachyplesin I at 37t for 15 min, en-
     zyme was added to the sample solution and incubated. DNA was recovered by ethanol precipita-
     tion following phenol/chloroform-extract procedures. The electrophoresis was performed by using 
     a 1 % agarose containing ethidium bromide (0.5 pg/m1) .
  Enzyme Recognition SiteInhibition of Enzyme Activity' 
lb 10 40 100  
Dral 5'-TTTAAA-3'+ + ++ ++ 
 SspI 5'-AATATT-3'- + + ++ 
 EcoRI 5'-GAATTC-3'- + + ++ 
 EcoRV 5'-GATATC-3'+ + + ++ 
 BamHI 5'-GGATCC-3'± + + ++ 
BanII 5'-GPuGCPyC-3'± + + ++ 
SmaI` 5'-CCCGGG-3'+ + ++ ++ 
Sall 5'-GTCGAC-3'- + + ++ 
FokI 5'-GGATGN9-3'+ +±± + + 
a. Partial and complete inhibition are represented by the symbol "+" and "++". 
b. Concentration of tachyplesin I (pg/ml) . 
c. Substrate DNA is Eco0109-linearized plasmid pUC19. 
suppressed restriction cleavage at all of these sites. Partial or complete inhibition of restric-
tion enzyme activities was detected at — 10 p g/ml or 40 100 p g/ml of tachyplesin I, 
respectively. It was previously demonstrated that distamycin A interferes with restriction en-
zyme [7,8] . This compound inhibits more effectively the activities of the enzymes recognized 
AT-rich DNA sites than those of the enzymes recognized GC-rich sites. In contrast, tachyple-
sin I inhibited evenly specific DNA cutting by many kinds of restriction enzymes. The result 
suggests that tachyplesin I possesses low sequence-specificity on DNA binding. Indeed, 3-
azidoamsacrine and polyamine which relatively nonspecifically bind to DNA, inhibit the acti-
vities of various restriction enzymes [9,10] . 
   Plasmid pBR322 contains three cutting sites for the restriction enzyme DraI or Rsal. All 
sites for DraI were evenly blocked from enzymatic cleavage by tachyplesin I (Figure 2) . 
Whereas, a careful titration with tachyplesin I revealed that the endonucleolytic cleavage at 
each recognition site of Rsal was inhibited at different concentration of the peptide (Figure 
4A) . In the presence of 20 pg/ml of tachyplesin I, the peptide masked the two recognition 
sites of Rsal and DNA was digested only at one site (position 165) (lane 9 in Figure 4A and 
illustration of Figure 4B) . Similar non-equivalent inhibition by distamycin A or actinomycin 
D among DNA cleavage sites with restriction enzyme has also been reported [8,11] . The 
observation has been interpreted as differences of their flanking sequences and/or an altera-
tion of the conformation at and around the recognition site of the enzyme. Inhibition and en-
hancement of DNA cleavage by bleomycin-Fe (II) , which is sensitive to conformational distor-
tion of DNA double helix [12,13] , were detected in our previous result [4] . Presumably, the 
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non-equivalent inhibition of tachyplesin I on the digestion with  Rsal is caused by differences 
of sequences and/or conformational alterations in the vicinity of the recognition site of the en-
zyme by the peptide binding to DNA. 
   The low sequence-specificity of tachyplesin I and its binding influence on the flanking re-
gion of binding sites may cause to inhibit specific-interaction of DNA binding proteins with 
various target sequences. Specific binding of transcription factor Spl to their DNA recogni-
tion sites, GC box sequence, has been detected by methylation protection analysis [13-15] . 
Since tachyplesin I does not entirely inhibit or enhance methylation of the N-7 site of 
guanines as described in our previous paper [4] , we applied the methylation protection analy-
sis to investigate the competition of tachyplesin I with Spl. The C-terminal 165-residues frag-
ment of Spl containing three Cys2His2 zinc fingers, designated Spl (167*) [5] , was used as 
Spl. Figure 5 shows the competition patterns of tachyplesin I with DNA binding of Spl to 
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            Figure 5. Competition of tachyplesin I for DNA binding of Spl by 
                  methylation protection analysis. Before addition of Spl (2.3 u 
                   M) , the DNA was preincubated with the following concentration 
                  of tachyplesin I: lane 4, 0 ug/m1; lane 5, 10 ug/m1; lane 6, 25,u 
                  g/ml; lane 7, 50 ug/m1; and lane 8, 100 ug/ml. Lane 3 shows 
                   the control pattern of DMS modification. Lanes 1 and 2 exhibit 
                  intact DNA and DNA sequencing (G+A) by Maxam-Gilbert 
                   method, respectively. Arrowhead and shaded box indicate the 
                  enhanced and inhibited methylation sites by Spl. 
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 DNA fragment from plasmid pBR322 containing pseudo GC box. In comparison with the 
 methylation pattern by DMS without Spl and tachyplesin I (lane 3) , inhibition (shaded box) 
 and enhancement (arrowhead) of  methylation at guanine residues in pseudo GC box were 
 observed in the presence of 2.3 uM Spl (lane 4) . Preincubation of the labeled DNA frag-
 ment with tachyplesin I clearly inhibited the formation of Spl-DNA complex depending upon 
 the concentration of the peptide (lanes 5-8) . Very recently, it was shown an instance that 
 minor groove-binding peptide and a major groove-binding protein can simultaneously bind to 
 a common site on DNA [16] . However, tachyplesin I which interacts in the minor groove of 
 DNA [4] appears to influence significantly to the binding of proteins in the major groove. Our 
 results also imply that tachyplesin I may inhibit the biological action of sequence-specific 
 DNA-binding proteins. 
    Herein, we clearly demonstrate that tachyplesin I inhibits DNA digestion with various 
 restriction enzymes and the binding of transcription factor Spl to GC box sequence. The re-
 sults strongly suggest non-specific binding of tachyplesin I for DNA sequences. 
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